Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Ikena Oncology, Inc. Banner

Ikena Oncology, Inc.

IKNA Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Net Income
-40.865m-16.817m-44.256m-34.115m-68.765m-68.166m
Depreciation & Amortization
422.000K243.000K300.000K544.000K751.000K1.020M
Change in Working Capital
58.000K63.453M-7.771m-33.032m-15.138m-21.669m
Operating Cash Flow
-11.608m47.927M-37.826m-60.252m-74.109m-79.743m
Capital Expenditure
-305.000k-316.000k-766.000k-1.760m-1.431m-414.000k
Free Cash Flow
-11.913m47.611M-38.592m-62.012m-75.540m-80.157m
Debt Repayment
0.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.000
Common Stock Issued
0.00016.316M116.184M131.302M1.095M37.557M
Common Stock Repurchased
0.0000.000-57.000k-146.000k0.000-663.000k
Net Change in Cash
-639.000k63.927M81.280M69.726M-172.298m59.975M